Literature DB >> 34790627

Cardiac Sodium Channel Blockade Due to Antiepileptic Drug Combination.

Ossama Maadarani1, Zouheir Bitar1, Abdelaziz Ashkanani1, Mahmoud Elzoueiry1, Mohamad Elhabibi1, Mohamad Gohar1, Mohamad Almuwaizri2, Sania Shoeb3, Jadan Alsaddah4.   

Abstract

Drugs that inhibit voltage-dependent sodium channels are commonly used to treat epilepsy. Old and novel antiepileptic drugs are used either as monotherapy or in combination to control epilepsy. For a long time, carbamazepine has been used as the first choice for the treatment of simple and complex partial seizures. In the USA, lacosamide was approved in October 2008 as an adjunctive treatment for partial-onset seizures. We describe the effect of two sodium channel blockers on the heart of a patient with epilepsy. LEARNING POINTS: Approximately 30% of patients with epilepsy require combination therapy with antiepileptic drugs for seizure reduction.Lacosamide and carbamazepine are both sodium channel blockers but exert their effects through different mechanisms.Electrocardiogram monitoring is necessary when lacosamide and carbamazepine are used together as this combination may predispose to seizures, conduction abnormalities and dysrhythmia. © EFIM 2021.

Entities:  

Keywords:  Sodium channel blockers; electrocardiogram; lacosamide

Year:  2021        PMID: 34790627      PMCID: PMC8592652          DOI: 10.12890/2021_002839

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


  9 in total

Review 1.  Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs.

Authors:  Philip N Patsalos; Emilio Perucca
Journal:  Lancet Neurol       Date:  2003-06       Impact factor: 44.182

Review 2.  Drug-resistant epilepsy.

Authors:  Patrick Kwan; Steven C Schachter; Martin J Brodie
Journal:  N Engl J Med       Date:  2011-09-08       Impact factor: 91.245

Review 3.  Pharmacological Treatment of Drug-Resistant Epilepsy in Adults: a Practical Guide.

Authors:  Martin J Brodie
Journal:  Curr Neurol Neurosci Rep       Date:  2016-09       Impact factor: 5.081

4.  In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy.

Authors:  Christopher E Nelson; Chady H Hakim; David G Ousterout; Pratiksha I Thakore; Eirik A Moreb; Ruth M Castellanos Rivera; Sarina Madhavan; Xiufang Pan; F Ann Ran; Winston X Yan; Aravind Asokan; Feng Zhang; Dongsheng Duan; Charles A Gersbach
Journal:  Science       Date:  2015-12-31       Impact factor: 47.728

5.  Lacosamide-induced second-degree atrioventricular block in a patient with partial epilepsy.

Authors:  Ahmad Nizam; Krishna Mylavarapu; Dwithiya Thomas; Klara Briskin; Brenda Wu; Deepak Saluja; Stephen Wong
Journal:  Epilepsia       Date:  2011-07-29       Impact factor: 5.864

Review 6.  Arrhythmia, heart rate variability, and antiepileptic drugs.

Authors:  T Tomson; G Kennebäck
Journal:  Epilepsia       Date:  1997-11       Impact factor: 5.864

Review 7.  Lacosamide: a review of preclinical properties.

Authors:  Bettina K Beyreuther; Joachim Freitag; Cara Heers; Niels Krebsfänger; Ute Scharfenecker; Thomas Stöhr
Journal:  CNS Drug Rev       Date:  2007

8.  Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide], lidocaine, and carbamazepine.

Authors:  Patrick L Sheets; Cara Heers; Thomas Stoehr; Theodore R Cummins
Journal:  J Pharmacol Exp Ther       Date:  2008-03-31       Impact factor: 4.030

9.  Ventricular tachycardia associated with lacosamide co-medication in drug-resistant epilepsy.

Authors:  Andrew C DeGiorgio; Tamara E Desso; Lance Lee; Christopher M DeGiorgio
Journal:  Epilepsy Behav Case Rep       Date:  2012-11-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.